SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
GERON
(NQNM:GERN Last Sale: 1.2 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (GERN : $1.2)
$240,434 million Market Cap at Market Close, July 1, 2022
Employs 160.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
230 Constitution Drive Research Report Earnings Snapshot - Last 11/05/18
Menlo Park, CA 94025 Fact Sheet
Phone: (650) 473-7700 Financial Statements
Fax: (650) 473-7701 Peer Comparison
Annual Reports

John A. Scarlett, CEO, David L. Greenwood, CFO
Nov 15, 2011, eliminated stem cell efforts to focus on cancer. First U.S. company to receive FDA clearance for human trials of a human embryonic stem cell based therapy, focused on spinal injuries, Jan 22, 2009. June 30, 2009 announced joint project to use stem cells to develop products, such as heart or liver cells derived from stem cells, which could replace animal trials, and give drug developers an early warning of whether new medicines are toxic. Focused on its telomerase technology, and cell-based therapeutics. March 10, 2004, announced License Agreement with Merix Bioscience for Therapeutic Cancer Vaccines. IPO at $8 July 30, 1996. Raised $16 MM, selling 2 MM shares, 68% of the outstanding. Secondary sold 6.5 million shares at $6.10, raising $40 million, Nov 11, 2004. Commensurate with purchase by MERCK of 2 million shares at $9, raising $18 million, Secondary sold 6.9 million shares at $9, raising $62.1 million, Sept 22, 2005. Founded in 1990.
Historical Charts    Technical Analysis
No Historical Data available for GERN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common GERN $1.2 $1.2 0 .0 $1.15 $1.21 1,000,333 $1.15 $1.21 200,361,848
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $240,434,218

A1383
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex